← Leaderboards
Susana Adriana Laucella
Eva Peron Acute Interzonal Gen Hospital
$1,736,847
Attributed
$1,736,847
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $135.8K · FY2010–23$200K$150K$100K$50K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,736,847 · 3
By mechanism
R01$1,736,847 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Parasites”
- Stephen Lev Hoffman · Sanaria, Inc.$58,168,134
- L David Sibley · Washington University$47,818,729
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,087,946
- Wilhelmus G. J. Hol · University Of Washington$32,390,237
- Philip Jon Rosenthal · University Of California San Francisco$31,794,731
- Daniel F. Hoft · Saint Louis University$31,137,771
Research focus
ParasitesInfectionT Cell ResponseTrypanosoma CruziPhenotypeBenznidazoleResponseChagas DiseaseT-LymphocyteChronicChildAftercareAntigensImmuneBaseMemoryFundingInnovationMyocarditisAntibodiesChronic PhaseB-LymphocytesExhaustCytokine
Grant awards (15)
Correlates of innate and T-cell immunity in seropositive and serodiscordant subjects for Trypanosoma cruzi infection.$135,000
R01 · FY2023 · AI · contact PI
Correlates of innate and T-cell immunity in seropositive and serodiscordant subjects for Trypanosoma cruzi infection.$135,000
R01 · FY2022 · AI · contact PI
Correlates of innate and T-cell immunity in seropositive and serodiscordant subjects for Trypanosoma cruzi infection.$135,000
R01 · FY2021 · AI · contact PI
Correlates of innate and T-cell immunity in seropositive and serodiscordant subjects for Trypanosoma cruzi infection.$135,000
R01 · FY2020 · AI · contact PI
Correlates of innate and T-cell immunity in seropositive and serodiscordant subjects for Trypanosoma cruzi infection.$133,800
R01 · FY2019 · AI · contact PI
Immune competence as a factor of treatment efficacy in human Trypanosoma cruzi in$135,756
R01 · FY2018 · AI · contact PI
Immune competence as a factor of treatment efficacy in human Trypanosoma cruzi in$129,631
R01 · FY2017 · AI · contact PI
Immune competence as a factor of treatment efficacy in human Trypanosoma cruzi in$130,684
R01 · FY2016 · AI · contact PI
Immune competence as a factor of treatment efficacy in human Trypanosoma cruzi in$132,732
R01 · FY2015 · AI · contact PI
Immune competence as a factor of treatment efficacy in human Trypanosoma cruzi in$132,922
R01 · FY2014 · AI · contact PI
Development of T cell memory in human Trypanosoma cruzi infection$95,587
R01 · FY2013 · AI · contact PI
Development of T cell memory in human Trypanosoma cruzi infection$1
R01 · FY2013 · AI · contact PI
Development of T cell memory in human Trypanosoma cruzi infection$102,717
R01 · FY2012 · AI · contact PI
Development of T cell memory in human Trypanosoma cruzi infection$102,083
R01 · FY2011 · AI · contact PI
Development of T cell memory in human Trypanosoma cruzi infection$100,934
R01 · FY2010 · AI · contact PI